Key result
Recent aspirin use before acute myocardial infarction was associated with a lower likelihood of Q-wave infarction compared to nonusers (adjusted OR 0.77; 95% CI 0.61-0.97; P=0.03).
Why the study?
Does recent aspirin use reduce infarct size and the likelihood of Q-wave infarction in patients with acute myocardial infarction who do not receive thrombolytic therapy?
Population
2,206 patients with acute myocardial infarction who did not receive thrombolytic therapy.
Comparison
Aspirin use in the 4 days before myocardial… vs No aspirin use in the 4 days before myocardial…
Design
Cohort
Authors
Loading...
Recent aspirin use may limit infarct size; leaves open whether pre-MI aspirin improves outcomes in observational cohorts.
Observational (n=3,665)
Does recent aspirin use reduce infarct size and the likelihood of Q-wave infarction in patients with acute myocardial infarction who do not receive thrombolytic therapy?
Odds Ratio: 0.77 (95% CI 0.61–0.97)
Absolute Event Rate: 38.9% vs 48.7%
p-value: p=0.03
Recent aspirin use prior to acute myocardial infarction is associated with smaller infarct size and a lower likelihood of Q-wave infarction in patients not receiving thrombolytic therapy.
Mukamal et al. (1999) conducted an observational in acute myocardial infarction (n=3,665). Recent aspirin use vs. Nonusers was evaluated on Q-wave infarction (adjusted OR 0.77, 95% CI 0.61 to 0.97, p=0.03). Recent aspirin use before acute myocardial infarction was associated with a lower likelihood of Q-wave infarction compared to nonusers (adjusted OR 0.77; 95% CI 0.61-0.97; P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: